The Bancorp TBBK 深 滬
等待開盤 08-10 09:30:00 美东时间
69.64
-1.110
-1.57%
華盛通- 最 高70.81
- 今 開70.54
- 成交量 28.73万股
- 最 低 69.47
- 昨 收 70.75
- 總市值 28.99亿
- 52周最高 81.6526
- 市盈率 靜 14.17
- 換手率 0.69%
- 52周最低 50.20
- 委 比 -25.58%
- 總股本 4163.44万
- 歷史最高 81.6526
- 量 比 0.54
- 振 幅 1.89%
- 歷史最低 3.36
- 每 手 1
- 風險率 7.89%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多财报速睇 | The Bancorp 2026财年Q2营收1.64亿美元，同比下降9.8%；归母净利润0.61亿美元，同比增长1.4%
华盛资讯8月7日讯，The Bancorp公布2026财年Q2业绩，公司Q2营收1.64亿美元，同比下降9.8%，归母净利润0.61亿美元，同比增长1.4%。
08-07 02:33
美股大行评级 | 潜在涨幅3586.64%！HC Wainwright上调Enlivex目标价至80美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从20美元升至80美元；Canaccord Genuity：维持Pharming Group NV Sponsored ADR"买入"评级，目标价从37美元升至38美元
08-04 11:45
Piper Sandler Reiterates Overweight on Bancorp, Raises Price Target to $86
Piper Sandler analyst Manuel Navas reiterates Bancorp (NASDAQ:TBBK) with a Overweight and raises the price target from $70 to $86.
08-03 23:52
Bancorp Affirms FY2027 GAAP EPS Guidance of $8.10-$8.30 vs $8.07 Est
Bancorp (NASDAQ:TBBK) affirms FY2027 GAAP EPS guidance from $8.10-$8.30 to $8.10-$8.30 vs $8.07 analyst estimate..
07-31 04:14
SNDL Announces Completion of Parallel Asset Acquisition and Positions for Nasdaq-Consolidated U.S. Medical Cannabis Operations
SNDL Inc. completes acquisition of Parallel assets, a U.S. cannabis operator in Florida, Texas, and Massachusetts, reducing legacy debt and gaining indirect majority exposure. The transaction includes 56 retail locations and 3 cultivation facilities, with annual revenue of $150M. SNDL now operates 249 stores globally, leveraging Canadian market expertise for growth in key U.S. medical cannabis markets. CEO Zach George highlights the milestone in ...
07-27 15:48
美股大行评级 | 潜在涨幅246.92%！HC Wainwright & Co.上调Rockwell Medical(RMTI)目标价至20美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Rockwell Medical"买入"评级，目标价从2美元升至20美元；Canaccord Genuity：维持创力"买入"评级，目标价从10.5美元升至11美元
07-10 17:36
The Bancorp jumps 7% after KBW rating upgrade
Shares of The Bancorp (TBBK) rose around 7% after KBW upgraded the stock to "Outperform" from its previous rating and set a price target of $77, implying further upside from current levels. The broker...
07-10 00:41
This Cinemark Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Goldman Sachs analyst Mike Burton upgraded Cinemark Holdings, Inc. (NYSE:CNK) from Sell to Neutra...
07-09 19:32
